Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.

Kara T, Akata D, Akyol F, Karçaaltıncaba M, Özmen M.

Diagn Interv Radiol. 2011 Mar;17(1):38-43. doi: 10.4261/1305-3825.DIR.3079-09.1. Epub 2010 Aug 12.

2.

T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy.

Westphalen AC, Kurhanewicz J, Cunha RM, Hsu IC, Kornak J, Zhao S, Coakley FV.

Int Braz J Urol. 2009 Mar-Apr;35(2):171-80; discussion 181-2.

3.

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. Epub 2007 Sep 19.

PMID:
17881141
4.

Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.

Pucar D, Hricak H, Shukla-Dave A, Kuroiwa K, Drobnjak M, Eastham J, Scardino PT, Zelefsky MJ.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):62-9.

PMID:
17707266
5.

Detection of recurrent prostate cancer after cryosurgery.

Parivar F, Kurhanewicz J.

Curr Opin Urol. 1998 Mar;8(2):83-6.

PMID:
17035847
6.

IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.

van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):291-303.

PMID:
16618584
7.

Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.

Pucar D, Shukla-Dave A, Hricak H, Moskowitz CS, Kuroiwa K, Olgac S, Ebora LE, Scardino PT, Koutcher JA, Zakian KL.

Radiology. 2005 Aug;236(2):545-53. Epub 2005 Jun 21.

8.

Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience.

Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M 3rd, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J.

Radiology. 2004 Nov;233(2):441-8. Epub 2004 Sep 16.

PMID:
15375223
9.

Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.

Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1196-207.

PMID:
15234056
10.

Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning.

Cellini N, Morganti AG, Mattiucci GC, Valentini V, Leone M, Luzi S, Manfredi R, Dinapoli N, Digesu' C, Smaniotto D.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):595-9.

PMID:
12062602
11.

Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study.

Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll PR, Bessette A, Scheidler J, Srivastava A, Males RG, Cha I, Kurhanewicz J.

Radiology. 2001 Nov;221(2):380-90.

PMID:
11687679
12.

Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy.

Xia P, Pickett B, Vigneault E, Verhey LJ, Roach M 3rd.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):244-54.

PMID:
11516874
13.

Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity.

Menard C, Smith IC, Somorjai RL, Leboldus L, Patel R, Littman C, Robertson SJ, Bezabeh T.

Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):317-23.

PMID:
11380217
14.

Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.

Zelefsky MJ, Cohen G, Zakian KL, Dyke J, Koutcher JA, Hricak H, Schwartz L, Zaider M.

Cancer J. 2000 Jul-Aug;6(4):249-55.

PMID:
11038145
15.

Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.

Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J.

J Urol. 2000 Aug;164(2):400-4.

PMID:
10893595
16.

Supplemental Content

Support Center